Intersect ENT Competitors and Similar CompaniesClear all

Intersect ENT's competitors and similar companies include Stryker and Regeneron Pharmaceuticals.

	Intersect ENT Intersect ENT (also known as Medtronic Ear, Nose & Throat) is an ear, nose, and throat medical technology company.	Stryker Stryker is a company that develops medical, surgical, neurotechnology, orthopedics, and spine products.	Regeneron Pharmaceuticals Regeneron Pharmaceuticals is a biopharmaceutical company that develops, manufactures, and markets medicines.
Founding Date	Founding Date 2003	Founding Date 1941	Founding Date 1988
Type	Type Subsidiary	Type Public	Type Public
Tags	Tags Healthcare medical devices medtech	Tags Healthcare medical devices surgical solutions	Tags Healthcare biotech clinical research drug development pharma
Locations	Locations Menlo Park, US HQ	Locations Portage, US HQ Munro, AR Sydney, AU Vienna, AT Machelen, BE São Paulo, BR London, CA see more	Locations Tarrytown, US HQ Mississauga, CA Courbevoie, FR München, DE Bengaluru, IN Dublin, IE Limerick, IE see more
Employees	Employees 4337% increase	Employees 53,0002% increase	Employees 15,1068% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) 135 b	Valuation ($) 102.2 b
Financial
Revenue (est.)	Revenue (est.) $106.7m (FY, 2021)	Revenue (est.) $25.1b (FY, 2025)	Revenue (est.) $14.3b (FY, 2025)
Cost of goods	Cost of goods $30m (FY, 2021)	Cost of goods $9.1b (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit $76.7m (FY, 2021)	Gross profit $16.1b (FY, 2025)	Gross profit N/A
Net income	Net income ($159.6m) (FY, 2021)	Net income $3.2b (FY, 2025)	Net income $4.5b (FY, 2025)
Operating ⚠
Patents (US)	Patents (US) 30 (FY, 2016)	Patents (US) N/A	Patents (US) 31 (FY, 2020)
Products	Products 2 (FY, 2016)	Products N/A	Products 11 (FY, 2022)
Trademarks	Trademarks 29 (FY, 2016)	Trademarks N/A	Trademarks 20 (FY, 2022)
Funding
Total funding raised	Total funding raised $ 102.9m	Total funding raised N/A	Total funding raised $ 53.9m